$2.12
-0.09 (-4.07%)
OS Therapies Incorporated (OSTX)
OS Therapies Incorporated (OSTX) is a biotechnology company focused on developing innovative gene therapies for rare and serious genetic disorders. The company leverages advanced genetic engineering technologies to create treatments aimed at addressing unmet medical needs.
Company News
Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities
Several biotech companies are advancing cancer research with promising clinical milestones, focusing on innovative immunotherapies and targeted treatments amid rising cancer incidence and potential research funding challenges.